{
    "title": "AstraZeneca sees $4B in COVID vaccine sales as revenue soars",
    "url": "https://www.dailymail.co.uk/wires/ap/article-10497621/AstraZeneca-sees-4B-COVID-vaccine-sales-revenue-soars.html",
    "date": "2022-02-10",
    "keywords": [
        "astrazeneca",
        "revenue",
        "vaccine",
        "company",
        "covid19",
        "increase",
        "drug",
        "alexion",
        "profit",
        "time",
        "exchange",
        "oxford",
        "research",
        "london",
        "ap",
        "jump",
        "coronavirus",
        "year",
        "part",
        "boost",
        "university",
        "loss",
        "purchase",
        "acquisition",
        "percentage",
        "file",
        "soriot",
        "thursday",
        "drugmaker",
        "november",
        "shot",
        "cost",
        "agreement",
        "pfizer",
        "record",
        "inclusion",
        "worth",
        "disease",
        "business",
        "unit",
        "group",
        "view",
        "logo",
        "cambridge",
        "england",
        "saturday",
        "photoalastair",
        "grant",
        "chief",
        "executive",
        "promise",
        "access",
        "supply",
        "world",
        "growth",
        "trajectory",
        "development",
        "productivity",
        "blockbuster",
        "integration",
        "dividend",
        "decade",
        "stock",
        "morning"
    ],
    "category": [
        "wires",
        "ap"
    ]
}